Current Opinion in Chemical Biology

Current Opinion in Chemical Biology

CURRENT OPINION IN CHEMICAL BIOLOGY AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.2 • Impact Factor p.2 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.4 ISSN: 1367-5931 DESCRIPTION . Excellence paves the way with Current Opinion in Chemical Biology Current Opinion in Chemical Biology is a systematic review journal that aims to provide specialists with a unique and educational platform to keep up to date with the expanding volume of information published in the field of Chemical Biology. The journal publishes 6 issues per year covering the following 10 sections, each of which is reviewed once a year, these are: Omics, Biocatalysis and Biotransformation, Bioinorganic Chemistry, Next Generation Therapeutics, Molecular Imaging, Chemical Genetics and Epigenetics, Synthetic Biology, Synthetic Biomolecules and Mechanistic Biology. There is also a section that changes regularly to reflect hot topics in the field. Current Opinion in Chemical Biology builds on Elsevier's reputation for excellence in scientific publishing. It is a companion to the new Gold Open Access journal Current Research in Chemical Biology and is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy of editorial excellence, high-impact, and global reach to ensure they are a widely read resource that is integral to scientists' workflow. Expertise - Editors and Editorial Board bring depth and breadth of expertise and experience to the journal. Discoverability - Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast global audience. Ethics in Publishing: General Statement - The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. For more information, please refer to https://www.elsevier.com/conflictsofinterest Benefits to authors - We also provide many author benefits, such as a customized Share Link providing 50 days free access to the final published version of the article on ScienceDirect, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center AUTHOR INFORMATION PACK 24 Sep 2021 www.elsevier.com/locate/cbi 1 AUDIENCE . Chemical Biologists in academia and industry who are interested in keeping abreast of advances in understanding chemical biology. IMPACT FACTOR . 2020: 8.822 © Clarivate Analytics Journal Citation Reports 2021 ABSTRACTING AND INDEXING . Cambridge Scientific Abstracts Chemical Abstracts Embase Current Contents - Life Sciences Reference Update Science Citation Index PubMed/Medline Scopus EDITORIAL BOARD . Editor-in-Chief Dan Yang, The University of Hong Kong, Hong Kong, China Editorial Board Jacqueline K. Barton, Pasadena, California, United States of America Hagan Bayley, Oxford, United Kingdom Thomas Cech, Boulder, Colorado, United States of America Michelle Chang, Berkeley, California, United States of America Peng Chen, Beijing, China Jason Chin, Cambridge, United Kingdom Benjamin F. Cravatt, La Jolla, California, United States of America Bianxiao Cui, Stanford, California, United States of America Benjamin G. Davis, Oxford, United Kingdom William F. DeGrado, San Francisco, California, United States of America Peter B. Dervan, Pasadena, California, United States of America Alan R. Fersht, Cambridge, United Kingdom Harry B. Gray, Pasadena, California, United States of America Jay Groves, Berkeley, California, United States of America Itaru Hamachi, Kyoto, Japan Chuan He, Chicago, Illinois, United States of America Paul J. Hergenrother, Champaign, Illinois, United States of America Donald Hilvert, Zurich, Switzerland Philipp Holliger, Cambridge, United Kingdom Linda Hsieh-Wilson, Pasadena, California, United States of America Barbara Imperiali, Cambridge, Massachusetts, United States of America Daniel Kahne, Cambridge, Massachusetts, United States of America Stephen Kent, Chicago, Illinois, United States of America Chaitan Khosla, Stanford, California, United States of America Thomas Kodadek, Jupiter, Florida, United States of America Jean-Marie Lehn, Strasbourg, France David Liu, Cambridge, Massachusetts, United States of America Tetsuo Nagano, Tokyo, Japan Tom O'Halloran, Evanston, Illinois, United States of America Emily Parker, Wellington, New Zealand Richard Payne, Sydney, New South Wales, Australia Lawrence Que, Minneapolis, Minnesota, United States of America Ronald Raines, Cambridge, Massachusetts, United States of America Jianghong Rao, Stanford, California, United States of America Floyd Romesberg, San Diego, California, United States of America Alanna Schepartz, Berkeley, California, United States of America AUTHOR INFORMATION PACK 24 Sep 2021 www.elsevier.com/locate/cbi 2 Stuart L. Schreiber, Cambridge, Massachusetts, United States of America Peter G. Schultz, La Jolla, California, United States of America Peter H. Seeberger, Potsdam, Germany Scott K. Silverman, Champaign, Illinois, United States of America Hiroaki Suga, Tokyo, Japan Stephen Withers, Vancouver, British Columbia, Canada Catherine Wong, Beijing, China Chi-Huey Wong, La Jolla, California, United States of America AUTHOR INFORMATION PACK 24 Sep 2021 www.elsevier.com/locate/cbi 3 GUIDE FOR AUTHORS . Introduction The Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. In the Current Opinion journals, we help the reader by providing in a systematic manner: (1) The views of experts on current advances in the field in a clear and readable form. (2) Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications. The aim of the manuscript is to review recent articles, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, you are encouraged to give your subjective opinion of the topics discussed, although you should not concentrate unduly on your own research. Your review should be approximately 2000 words (not including references or reference notes), with approximately 50 references and, as such, the review is intended to be a concise view of the field as it is at the moment, rather than a comprehensive overview. Our audience ranges from student to professor, so articles must be accessible to a wide readership. Please avoid jargon, but do not oversimplify: be accurate and precise throughout. Occasionally, unpublished data can be referred to, but only when essential and should never be used to substantiate any significant point. Submission to this journal is by invitation only. Please contact your Editorial Manager by email if you have any questions, Ms. Joanna Aldred [email protected]. Submission Checklist You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details. Ensure that the following items are present: One author has been designated as the corresponding author with contact details: • E-mail address • Full postal address All necessary files have been uploaded: Manuscript: • Include keywords • All figures (include relevant captions) • All tables (including titles, description, footnotes) • Ensure all figure and table citations in the text match the files provided • Indicate clearly if color should be used for any figures in print Graphical Abstracts / Highlights files (where applicable) Supplemental files (where applicable) Further considerations • Manuscript has been 'spell checked' and 'grammar checked' • All references mentioned in the Reference List are cited in the text, and vice versa. Self-citations should be kept to a minimum and not exceed 20% of the total number of listed references • Permission has been obtained for use of copyrighted material from other sources (including the Internet) • A competing interests statement is provided, even if the authors have no competing interests to declare • Journal policies detailed in this guide have been reviewed • Referee suggestions and contact details provided, based on journal requirements For further information, visit our Support Center. BEFORE YOU BEGIN Ethics in publishing Please see our information on Ethics in publishing. AUTHOR INFORMATION PACK 24 Sep 2021 www.elsevier.com/locate/cbi 4 Declaration of competing interest All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/ registrations, and grants or other funding. Authors should complete the declaration of competing interest statement using this template and upload to the submission system at the Attach/Upload Files step. Note: Please do not convert the .docx template to another file type. Author signatures are not required. If there are no interests to declare, please choose the first option in the template. More information. Author contributions For transparency, we encourage authors to submit an author statement file outlining

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    12 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us